Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
📰 News Media
- 💉 [Duluth, Minnesota] Needle exchange programs at risk of closure as state funding dries up - minnpost.com
- 🌿 [National] U.S. Senate throws Minnesota’s hemp-based THC drinks and gummies industry a lifeline - minnpost.com
- 🧠 [International] The Representation Crisis: The Problem in the Medicalised Psychedelics Model - talkingdrugs.org
- 🌿 [La Mesa, CA] La Mesa, city with lowest cannabis tax in county, votes to raise levy to 5% - timesofsandiego.com
🗣️ Social Pulse
Lived/Living Experience
Innovation
- 🧠 New synthetic compounds continue to emerge, challenging responders and forensic laboratories alike. Our Adaptive Cycle of Synthetic Opioids white paper explores why field intelligence must evolve just as quickly.... - @908Devices on X
- 🚑 Manitoba opens first safe consumption site amid public debate over drug policy 🤖 IA: It's clickbait ⚠️ 👥 Users: It's clickbait ⚠️ #safeconsumptionsites #publichealthpolicy View full AI summary: - @killbaitcanada on Bluesky
Opposition Views
🏙 City Updates
- No recent City Updates found.
📚 Academic Research
- 💊 Opioid, Buprenorphine, Benzodiazepine, Naloxone, and Stimulant Prescriptions Dispensed to Rhode Island Residents, 2022-2025. - PubMed - 2026-08-01 - pubmed.ncbi.nlm.nih.gov
- 🤖 “Smart” harm reduction vending machines to improve public health: Evaluating the utilization - Journal of Substance Use and Addiction Treatment - 2026-08-01 - doi.org
- 📱 Leveraging Social Media to Disseminate Evidence-Based Messaging About Substance Use to Reduce Stigma and Promote Harm Reduction in Adolescents and Young Adults - Substance Use & Misuse - 2026-07-29 - doi.org
⚖️ Law & Policy
- No hits in Law and Policy today.
💸 Funding
Current
- 🩺 Centers for Disease Control-GHC - Improving regional capacity to respond to HIV, TB, and other global health priorities in Central America - Deadline: Aug 31, 2026
- 🔬 National Institutes of Health - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) - Deadline: Sep 30, 2026
- 🔬 National Institutes of Health - Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed) - Deadline: Oct 1, 2026
- 🔬 National Institutes of Health - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) - Deadline: Aug 21, 2028
- 🔬 National Institutes of Health - Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) - Deadline: Sep 25, 2028
- 🔬 National Institutes of Health - HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) - Deadline: Feb 9, 2029
- 🏥 Hearst Foundations - Social Service - Hearst Foundations — Social Service (Year-round rolling applications via Grants Portal) - Minimum grant size is $100,000. - Deadline: Year-round rolling application; there are no deadlines.
- 🏥 Hearst Foundations - Health - Hearst Foundations — Year-Round, Rolling Grant Applications (Health priority area) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- 🤝 Smart Family Fund - First time grants ranging from $25,000 to $100,000. - Deadline: Open pitch